VEGFA and endometrial cancer: Therefore, studying the expression of related angiogenic factors, such as vascular endothelial growth factor, at the molecular level in endometrial cancer, and developing targeted therapeutic drugs based on their targets, will provide new ideas for clinical treatment and prognosis monitoring of endometrial cancer.